A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer

NCT02138955 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients w/Advanced Cancer That Failed Std of Care Therapy

Interventions

DRUG: Liposomeal curcumin

Sponsor

SignPath Pharma, Inc.